E. AKDAŞ Et Al. , "Real-life clinical practice with omalizumab in 134 patients with refractory chronic spontaneous urticaria: a single-center experience," Anais Brasileiros de Dermatologia , vol.98, no.2, pp.240-242, 2023
AKDAŞ, E. Et Al. 2023. Real-life clinical practice with omalizumab in 134 patients with refractory chronic spontaneous urticaria: a single-center experience. Anais Brasileiros de Dermatologia , vol.98, no.2 , 240-242.
AKDAŞ, E., ADIŞEN, E., ÖZTAŞ, M. O., AKSAKAL, A. B., İLTER, N., & GÜLEKON, A., (2023). Real-life clinical practice with omalizumab in 134 patients with refractory chronic spontaneous urticaria: a single-center experience. Anais Brasileiros de Dermatologia , vol.98, no.2, 240-242.
AKDAŞ, ELÇİN Et Al. "Real-life clinical practice with omalizumab in 134 patients with refractory chronic spontaneous urticaria: a single-center experience," Anais Brasileiros de Dermatologia , vol.98, no.2, 240-242, 2023
AKDAŞ, ELÇİN Et Al. "Real-life clinical practice with omalizumab in 134 patients with refractory chronic spontaneous urticaria: a single-center experience." Anais Brasileiros de Dermatologia , vol.98, no.2, pp.240-242, 2023
AKDAŞ, E. Et Al. (2023) . "Real-life clinical practice with omalizumab in 134 patients with refractory chronic spontaneous urticaria: a single-center experience." Anais Brasileiros de Dermatologia , vol.98, no.2, pp.240-242.
@article{article, author={ELÇİN AKDAŞ Et Al. }, title={Real-life clinical practice with omalizumab in 134 patients with refractory chronic spontaneous urticaria: a single-center experience}, journal={Anais Brasileiros de Dermatologia}, year=2023, pages={240-242} }